KM Financial Solutions | AbbVie-Allergan $63 bln deal aided by Nestle, AstraZeneca buys
62955
post-template-default,single,single-post,postid-62955,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

AbbVie-Allergan $63 bln deal aided by Nestle, AstraZeneca buys

AbbVie-Allergan $63 bln deal aided by Nestle, AstraZeneca buys

U.S. drugmaker AbbVie’s
$63 billion tie-up with Allergan is getting help from
Nestle and AstraZeneca buying up products the
Irish-domiciled company is shedding to placate regulators.

No Comments

Sorry, the comment form is closed at this time.